First new treatment for asthma in 50 years

A study reveals Benralizumab as a new treatment for asthma and COPD, reducing treatment failure rates significantly.
Benralizumab, a monoclonal antibody, is already used for the long-term management of eosinophilic asthma, with studies still evaluating the effect of long-term management in eosinophilic COPD.